We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care toda... Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. Show more
Join Inspiraβ’ Technologies' Live Investor Webinar and Q&A Session on November 11 PR Newswire RA'ANANA, Israel, Nov. 8, 2024 RA'ANANA,Β Israel, Nov. 8, 2024 /PRNewswire/ --Β Inspira Technologies...
/C O R R E C T I O N -- Inspira Technologies/ PR Newswire RA'ANANA, Israel, Oct. 24, 2024 In the news release, Inspiraβ’ Announces Establishment of Distribution Facility to Support U.S. Deployment...
/C O R R E C T I O N -- Inspira Technologies/ PR Newswire RA'ANANA, Israel, Oct. 24, 2024 In the news release, Inspiraβ’ Announces Establishment of Distribution Facility to Support U.S. Deployment...
Inspiraβ’ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRAβ’ ART100 PR Newswire RA'ANANA, Israel, Oct. 24, 2024 The Company has signed a distribution...
Inspiraβ’ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism PR Newswire RA'ANANA, Israel, Oct. 9, 2024 RA'ANANA, Israel, Oct. 9, 2024 /PRNewswire/...
Inspiraβ’ Launches INSPIRAβ’ ART100 at the World's Largest Extracorporeal Life Support Conference PR Newswire RA'ANANA, Israel, Sept. 24, 2024 RA'ANANA, Israel, Sept. 24, 2024 /PRNewswire/...
Inspiraβ’ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System PR Newswire RA'ANANA, Israel, Sept. 13, 2024 To date, a combined total of 32 claims have been deemed...
Inspiraβ’ to Publish HYLAβ’ Clinical Results in Fourth Quarter 2024 PR Newswire RA'ANANA, Israel, Aug. 28, 2024 The clip-on HYLAβ’ blood sensor, designed to alert physicians of immediate signs of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -9.42028985507 | 1.38 | 1.45 | 1.22 | 186292 | 1.33279155 | CS |
4 | -0.16 | -11.3475177305 | 1.41 | 1.45 | 1.22 | 140199 | 1.34402675 | CS |
12 | 0.16 | 14.6788990826 | 1.09 | 1.49 | 1 | 131062 | 1.31348082 | CS |
26 | -0.92 | -42.3963133641 | 2.17 | 2.44 | 0.813 | 123621 | 1.43135341 | CS |
52 | -0.004 | -0.318979266348 | 1.254 | 2.49 | 0.7613 | 546449 | 1.35049426 | CS |
156 | -2.49 | -66.577540107 | 3.74 | 6.24 | 0.7613 | 875759 | 3.0573991 | CS |
260 | -3.75 | -75 | 5 | 9.59 | 0.7613 | 1128960 | 4.37351903 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions